MCGUIRK TERENCE F 4

4 · Atlanta Braves Holdings, Inc. · Filed Dec 15, 2025

Form 4

Period: 2025-12-11

Director

Transactions

Exercise/Conversion
Series C Common Stock
2025-12-11+15,042→ 255,383 total
Sale
Series C Common Stock
2025-12-12$39.72/sh−6,688$265,647→ 248,695 total
Exercise/Conversion
Restricted Stock Units - BATRK
2025-12-11−15,042→ 15,042 total
→ Series C Common Stock (15,042 underlying)

Holdings

Footnotes (6)

[F1]Each restricted stock unit converted into one share of Series C Common Stock.
[F2]The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units.
[F3]Reflects the weighted average sale price. The range of prices for such transaction is $39.37 to $40.12. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
[F4]Reflects shares held in a family trust for which the reporting person's spouse is trustee and the reporting person's children are beneficiaries.
[F5]Each restricted stock unit represents a contingent right to receive one share of Series C Common Stock.
[F6]One-third of the restricted stock unit award vested on each of December 11, 2024 and 2025, and the remaining restricted stock units vest on December 11, 2026.

Documents

1 file